SEC Filings

Filing date	Form	Description	View
11/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-015427.pdf 0001179110-15-015427.rtf 0001179110-15-015427.xls
11/24/15	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-015429.pdf 0001179110-15-015429.rtf 0001179110-15-015429.xls
11/12/15	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001104659-15-078317.pdf 0001104659-15-078317.rtf 0001104659-15-078317.xls EX-101.INS - XBRL INSTANCE DOCUMENT
11/10/15	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001213900-15-008373.pdf 0001213900-15-008373.rtf 0001213900-15-008373.xls
11/10/15	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001213900-15-008375.pdf 0001213900-15-008375.rtf 0001213900-15-008375.xls
11/10/15	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-15-077724.pdf 0001104659-15-077724.rtf 0001104659-15-077724.xls
11/10/15	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	View HTML 0001104659-15-077728.pdf 0001104659-15-077728.rtf 0001104659-15-077728.xls
11/09/15	8-K	Report of unscheduled material events or corporate event	View HTML 0001102624-15-001644.pdf 0001102624-15-001644.rtf 0001102624-15-001644.xls
10/26/15	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-15-072604.pdf 0001104659-15-072604.rtf 0001104659-15-072604.xls
10/26/15	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-15-008037.pdf 0001047469-15-008037.rtf 0001047469-15-008037.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.